OligoNova Network gathers research on drugs of the future

The conference was organized by OligoNova, Sweden’s national infrastructure for oligonucleotide therapies and part of the SciLifeLab Drug Discovery and Development platform (DDD). The Director of Science for OligoNova, Pär Matsson, hopes that the research network and the national infrastructure OligoNova Hub can benefit patients by discovering findings from academic research more quickly. As a result, the process of developing drugs for groups that currently lack treatment can be simplified.

“A number of online meetings have been held during the almost one and a half years that OligoNova has been active, but this was the first physical meeting, and also the first research meeting in Sweden that focuses entirely on the development of therapeutic oligonucleotides”, says Pär Matsson.

A national ecosystem

OligoNova Network is part of the larger OligoNova project. The network aims to establish a national ecosystem for the research field therapeutic oligonucleotides, promote interactions between academia and industry, and create conditions for research and development in the field.